Perkirol 0.25mg (Ropinirole) Tablet treats and relieves the symptoms of restless leg syndrome and Parkinson's disease.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Perkirol 0.25mg Tablet is a medication containing Ropinirole, which is classified as a dopamine agonist. It is prescribed for the treatment of Parkinson's disease and moderate to severe idiopathic Restless Legs Syndrome (RLS). Parkinson's disease is a progressive neurodegenerative condition that primarily affects the dopamine-producing neurons in the brain. Its symptoms include rigidity, tremors, impaired posture and gait, and drooling, with or without dementia. RLS is a central nervous system disorder characterized by an irresistible urge to move the legs or arms, often accompanied by tingling, burning, or prickling sensations. These symptoms typically occur during periods of rest or inactivity, especially in the evening or at night, and are worse when lying down or sitting.
Perkirol 0.25mg Tablet functions similarly to natural dopamine in the brain and helps alleviate the symptoms of Parkinson's disease and RLS. It is important to inform your doctor if you experience any unusual behavior while taking this medication, such as an unusual urge to gamble or increased sexual urges. The most common side effect of Perkirol 0.25mg Tablet is the potential worsening of RLS symptoms. You may notice that your symptoms start earlier than usual, become more intense, or affect limbs that were previously unaffected. Other possible side effects include dizziness, drowsiness, fatigue, nausea, vomiting, stomach pain, or dyskinesia (abnormal involuntary movements). If any of these symptoms become bothersome, it is advisable to contact your doctor for further guidance.
Avoid consumption of alcohol during treatment with Perkirol 0.25mg Tablet as it may increase the risk of side effects such as dizziness, drowsiness, and difficulty in concentration.
Limited information is available on the use of Perkirol 0.25mg Tablet in pregnancy. Use this medicine in pregnancy only if prescribed by your doctor.
Components of Perkirol 0.25mg Tablet are known to be excreted in milk, this medicine should be avoided if you are breastfeeding.
Do not drive or operate any machines, because this medicine may make you feel extremely drowsy.
Perkirol 0.25mg Tablet is not recommended for use in patients with severe kidney disease. Consult your doctor for advice.
Perkirol 0.25mg Tablet is not recommended for use in patients with severe liver disease. Consult your doctor for advice.
This medication works as a dopamine agonist with a high affinity for the D3 receptors concentrated in the limbic areas of the brain which is responsible for the neuropsychiatric effects and the affinity for D2 receptors account for the benefits on the motor symptoms of Parkinson’s disease.
Ropinirole is used for the treatment of -
Perkirol (Ropinirole) is a non-ergoline dopamine agonist that specifically targets and activates the D2 and D3 subtypes of dopamine receptors. Its precise mechanism of action in the treatment of Parkinson's disease and Restless Legs Syndrome (RLS) is not fully understood. However, it is believed that Perkirol works by stimulating these dopamine receptors, which helps to restore and regulate dopamine levels in the brain.
Dopamine is a neurotransmitter that plays a crucial role in motor control and movement. In Parkinson's disease, there is a deficiency of dopamine due to the degeneration of dopamine-producing neurons. By acting as a dopamine agonist, Perkirol can mimic the effects of dopamine and help alleviate the motor symptoms associated with Parkinson's disease, such as rigidity, tremors, and impaired movement.
In the case of Restless Legs Syndrome (RLS), the exact cause is not fully understood. However, dopamine dysfunction in the brain has been implicated as a contributing factor. By stimulating dopamine receptors, Perkirol may help regulate dopamine levels and alleviate the symptoms of RLS, such as the irresistible urge to move the legs or arms and associated discomfort or sensations.
It is important to note that while the mechanism of action of Perkirol involves dopamine receptor stimulation, the precise details of how it produces its therapeutic effects in Parkinson's disease and RLS are still under investigation.
It is important to note that the dosing information provided here is a general guideline, and actual dosages should be determined by a healthcare provider based on individual patient factors and response to treatment.
Perkirol 0.25mg Tablet can interact with certain medications and medical conditions. Here are some important interactions to be aware of:
Drug Interactions:
Antipsychotic medications (e.g., amisulpride): Perkirol 0.25mg Tablet may interact with antipsychotic medications, potentially increasing the risk of side effects. Close monitoring and dose adjustments may be necessary if using these medications together.
Analgesic medications (e.g., propoxyphene): There may be interactions between Perkirol 0.25mg Tablet and analgesic medications. Your doctor may need to adjust the doses of these medications or monitor you closely for any adverse effects.
Central nervous system depressants (e.g., sodium oxybate): Combining Perkirol 0.25mg Tablet with central nervous system depressants can enhance the sedative effects of both medications. Caution should be exercised, and your doctor may need to adjust the dosages accordingly.
Food Interactions:
Disease Interactions:
It is contraindicated in patients known to have a hypersensitivity to Ropinirole
Ropinirole is classified as pregnancy category C, indicating that there are no adequate and well-controlled studies available in pregnant women. Therefore, the use of Ropinirole during pregnancy should only be considered if the potential benefit to the mother outweighs the potential risk to the fetus.
It is important to discuss the potential risks and benefits with your healthcare provider before taking Ropinirole if you are pregnant or planning to become pregnant.
Additionally, Ropinirole has been shown to inhibit prolactin secretion in humans, which could potentially interfere with lactation. If you are breastfeeding or planning to breastfeed, it is important to consult with your doctor before taking Ropinirole.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.